Table 4. Number and proportion of respondents with COVID-19 symptoms by SARS-CoV-2 seropositivity status, Dublin and Sligo, Ireland, 22 June–16 July 2020 (n = 1,732).

Symptom/condition	Seropositive respondents (n = 33)			Seronegative respondents^a (n = 1,699)			p value^b
Symptom/condition	Yes	No	Not specified	Yes	No	Not specified	p value^b
Previous laboratory-confirmed SARS-CoV-2 infection	8	25	0	2	1,678	19	< 0.001
Close contact with someone with suspected or confirmed SARS-CoV-2 infection since February 2020	13	16	4	133	1,460	106	< 0.001
Fever	12	21	0	102	1,584	13	< 0.001
Chills	8	25	0	109	1,580	10	0.001
Fatigue	17	16	0	301	1,376	22	< 0.001
Muscle aches	14	19	0	186	1,501	12	< 0.001
Sore throat	6	27	0	261	1,427	11	0.629
Cough	13	20	0	293	1,401	5	0.004
Runny nose	7	25	1	304	1,385	10	0.641
Shortness of breath	6	26	1	164	1,527	8	0.123
Chest pain	5	27	1	97	1,598	4	0.037
Other respiratory symptoms	1	31	1	71	1,619	9	1.000
Headache	15	18	0	319	1,365	15	0.001
Loss of sense of smell (anosmia)	9	23	1	47	1,639	13	< 0.001
Loss of sense of taste (ageusia)	10	23	0	48	1,644	7	< 0.001
Loss of either sense of smell or taste (composite of previous two variables)	11	22	0	67	1,617	15	< 0.001
Sought medical attention for symptoms	18	12	0	193	1,432	74	< 0.001
Admitted to hospital for symptoms^c	2	28	0	15	1,594	90	0.037
Consistent with case definition^d	24	9	0	434	1,265	0	< 0.001
Asymptomatic	3	30	0	890	809	0	< 0.001

COVID-19: coronavirus disease; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2.

^a One serosurvey respondent was omitted because no information on symptoms existed.

^b Fishers exact test unweighted analyses

^c Only the symptomatic seropositive respondents were included for the seropositive respondents (n = 30).

^d Reported at least one of the following: fever, cough, shortness of breath, loss sense of smell or taste.